SE435291B - Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra - Google Patents

Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra

Info

Publication number
SE435291B
SE435291B SE7610722A SE7610722A SE435291B SE 435291 B SE435291 B SE 435291B SE 7610722 A SE7610722 A SE 7610722A SE 7610722 A SE7610722 A SE 7610722A SE 435291 B SE435291 B SE 435291B
Authority
SE
Sweden
Prior art keywords
yltiomethyl
sulfaminoethyl
cefem
tetrazol
acylamino
Prior art date
Application number
SE7610722A
Other languages
English (en)
Swedish (sv)
Other versions
SE7610722L (sv
Inventor
D A Berges
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of SE7610722L publication Critical patent/SE7610722L/xx
Publication of SE435291B publication Critical patent/SE435291B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7610722A 1975-10-30 1976-09-28 Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra SE435291B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them

Publications (2)

Publication Number Publication Date
SE7610722L SE7610722L (sv) 1977-05-01
SE435291B true SE435291B (sv) 1984-09-17

Family

ID=27417417

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7610722A SE435291B (sv) 1975-10-30 1976-09-28 Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE8006413A SE452621B (sv) 1975-10-30 1976-09-28 7-amino cefalosporinderivat till anvendning som mellanprodukt for framstellning av motsvarande 7-substituerade cefalosporinderivat
SE8006414A SE437025B (sv) 1975-10-30 1980-09-12 1-(2-sulfaminoetyl)-tetrazol-5-tiol till anvendning for framstellning av cefalosporinforeningar med antibakteriell aktivitet

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8006413A SE452621B (sv) 1975-10-30 1976-09-28 7-amino cefalosporinderivat till anvendning som mellanprodukt for framstellning av motsvarande 7-substituerade cefalosporinderivat
SE8006414A SE437025B (sv) 1975-10-30 1980-09-12 1-(2-sulfaminoetyl)-tetrazol-5-tiol till anvendning for framstellning av cefalosporinforeningar med antibakteriell aktivitet

Country Status (17)

Country Link
JP (1) JPS6053026B2 (xx)
AT (1) AT353957B (xx)
AU (1) AU505141B2 (xx)
CA (1) CA1071188A (xx)
CH (1) CH627757A5 (xx)
DE (1) DE2649545A1 (xx)
DK (1) DK463176A (xx)
ES (1) ES452769A1 (xx)
FI (1) FI60868C (xx)
FR (3) FR2361896A1 (xx)
GB (3) GB1570095A (xx)
GR (1) GR61667B (xx)
IE (1) IE44393B1 (xx)
IL (3) IL50546A (xx)
LU (1) LU76092A1 (xx)
NL (1) NL7612010A (xx)
SE (3) SE435291B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (de) * 1983-09-22 1987-08-25 Biochemie Gmbh Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
NL7414119A (nl) * 1973-10-31 1975-05-02 Fujisawa Pharmaceutical Co Werkwijze ter bereiding van 1h-tetrazool-5-thiol- derivaten en 1-gesubstitueerde 1h-tetrazool- -5-thiolen.
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
SE452621B (sv) 1987-12-07
AT353957B (de) 1979-12-10
SE8006413L (sv) 1980-09-12
ES452769A1 (es) 1978-01-16
AU1870276A (en) 1978-04-20
FR2351982B1 (xx) 1981-07-03
IL56757A0 (en) 1979-05-31
FR2351982A1 (fr) 1977-12-16
FR2337720A1 (fr) 1977-08-05
FI60868B (fi) 1981-12-31
FR2361896A1 (fr) 1978-03-17
LU76092A1 (xx) 1977-05-17
FR2361896B1 (xx) 1979-02-23
IE44393B1 (en) 1981-11-18
AU505141B2 (en) 1979-11-08
GB1570095A (en) 1980-06-25
ATA807276A (de) 1979-05-15
NL7612010A (nl) 1977-05-03
CH627757A5 (en) 1982-01-29
JPS5257191A (en) 1977-05-11
CA1071188A (en) 1980-02-05
GB1570093A (en) 1980-06-25
FI60868C (fi) 1982-04-13
GR61667B (en) 1978-12-05
GB1570094A (en) 1980-06-25
IL56758A0 (en) 1979-05-31
SE7610722L (sv) 1977-05-01
JPS6053026B2 (ja) 1985-11-22
IL50546A0 (en) 1976-11-30
FR2337720B1 (xx) 1981-07-10
IL50546A (en) 1980-07-31
FI763044A (xx) 1977-05-01
DK463176A (da) 1977-05-01
SE8006414L (sv) 1980-09-12
DE2649545A1 (de) 1977-05-12
IE44393L (en) 1977-09-11
SE437025B (sv) 1985-02-04

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE436572B (sv) Forfarande for framstellning av androstadien-17-karbonsyraestrar
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
SE441360B (sv) Forfarande for framstellning av fosfonsyraderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7802609L (sv) Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
NO141050C (no) Fremgangsmaate ved fremstilling av 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-ind-2-en-3-yl-eddiksyre
NO821484L (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
SE435291B (sv) Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
NO142121C (no) Fremgangsmaate til fremstilling av perpropionsyreopploesoninger
SE427184B (sv) Forfarande for framstellning av 7-aminocefalosporansyraderivat
SE414927B (sv) Forfarande for framstellning av 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler
SE428689B (sv) Forfarande for framstellning av aroyl-fenylnaftalenforeningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610722-6

Effective date: 19880622

Format of ref document f/p: F